Read More Pharma Industry News Lyell Immunopharma to acquire ImmPACT—are CAR T-cell therapies the future of oncology? Lyell Immunopharma is making waves with its strategic acquisition of ImmPACT Bio, a move aimed at bolstering its… byPallavi MadhirajuOctober 25, 2024